Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2006 | |
| Sales | 13,165 | 10,146 | 0 |
| Cost of Goods | 4,984 | 2,764 | N/A |
| Gross Profit | 8,181 | 7,383 | N/A |
| Operating Expenses | 9,025 | 8,769 | 0 |
| Operating Income | 140 | -623 | N/A |
| Other Income | 50 | 14 | 0 |
| Pre-tax Income | 190 | -609 | 0 |
| Net Income Continuous | 190 | -609 | N/A |
| Net Income | $190 | $-609 | $N/A |
| EPS Basic Total Ops | 0.02 | -0.06 | N/A |
| EPS Basic Continuous Ops | 0.02 | -0.06 | N/A |
| EPS Diluted Total Ops | 0.02 | -0.06 | N/A |
| EPS Diluted Continuous Ops | 0.02 | -0.06 | N/A |
| EBITDA(a) | $1,613 | $786 | $N/A |